Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: A secondary analysis of the AVERROES study

Stroke

Volumn 45, Issue 7, 2014, Pages 2127-2130

  Lip, Gregory Y H ^a   Eikelboom, John ^b   Yusuf, Salim ^b   Shestakovska, Olga ^b   Hart, Robert G ^b   Connolly, Stuart ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

aspirin; atrial fibrillation; hemorrhage; stroke

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; ATRIAL FIBRILLATION; HEMORRHAGE; STROKE;

AGE FACTORS; AGED; ASPIRIN; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; PYRAZOLES; PYRIDONES; SEX FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84903790238     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005746     Document Type: Article

References (9)

1. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, et al. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J. 2006;27: 1947-1953. (Pubitemid 44297369)
2. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364: 806-817.
3. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319: 1492-1495.
4. Wagstaff AJ, Overvad TF, Lip GY, Lane DA. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis [published online ahead of print March 14, 2014]. QJM. http://qjmed.oxfordjournals.org/content/ early/2014/03/14/qjmed.hcu054.full. pdf+html. Accessed April 7, 2014.
5. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49: 572-577. (Pubitemid 46177436)
6. Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY. Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: A systematic review and meta-analysis. Stroke. 2013;44: 1329-1336.
7. Cove CL, Albert CM, Andreotti F, Badimon L, Van Gelder IC, Hylek EM. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost. 2014;111: 385-391.
8. Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367: 625-635.
9. Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012;33: 2821-2830.